Insider Transactions in Q3 2025 at Health Sciences Acquisitions Corp 2 (HSAQ)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2025
|
Jason Aryeh Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.91%
|
$2,000
$2.45 P/Share
|
|
Sep 17
2025
|
David P Hochman Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,283
-0.73%
|
$6,566
$2.46 P/Share
|
|
Sep 17
2025
|
David P Hochman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
40,355
-6.19%
|
$80,710
$2.46 P/Share
|
|
Sep 17
2025
|
Andrew Lawrence Taylor Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,102
-3.34%
|
$32,204
$2.46 P/Share
|
|
Sep 17
2025
|
Joshua Aiello Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
203
-1.05%
|
$406
$2.46 P/Share
|
|
Sep 03
2025
|
Darren Sherman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
40,340
-4.35%
|
$80,680
$2.72 P/Share
|
|
Aug 25
2025
|
Eric S Fain Director |
BUY
Open market or private purchase
|
Indirect |
5,760
+7.44%
|
$11,520
$2.61 P/Share
|
|
Aug 25
2025
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.41%
|
$4,000
$2.55 P/Share
|
|
Aug 25
2025
|
Darren Sherman Director |
BUY
Open market or private purchase
|
Direct |
3,000
+0.32%
|
$6,000
$2.62 P/Share
|
|
Aug 21
2025
|
David P Hochman Director |
BUY
Open market or private purchase
|
Direct |
6,000
+0.91%
|
$12,000
$2.49 P/Share
|
|
Aug 07
2025
|
Connealy Pamela Yanchik Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+23.54%
|
-
|
|
Aug 07
2025
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+11.5%
|
-
|
|
Aug 07
2025
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+12.25%
|
-
|
|
Aug 07
2025
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+14.27%
|
-
|
|
Aug 07
2025
|
David Pacitti Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.01%
|
-
|
|
Aug 07
2025
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+18.2%
|
-
|
|
Aug 07
2025
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+13.41%
|
-
|
|
Aug 07
2025
|
Chris Cleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+28.53%
|
-
|
|
Aug 07
2025
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Indirect |
7,500
+11.37%
|
-
|
|
Aug 07
2025
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
-
|
|
Aug 07
2025
|
John Prosper Mack Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+27.13%
|
-
|
|
Aug 07
2025
|
Joshua Aiello Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+43.69%
|
-
|
|
Aug 04
2025
|
David P Hochman Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+5.42%
|
$40,000
$2.75 P/Share
|
|
Aug 01
2025
|
Perceptive Advisors LLC |
BUY
Open market or private purchase
|
Indirect |
700,000
+11.68%
|
$1,400,000
$2.75 P/Share
|